Join Us for Our Next Subscriber-Exclusive Webinar

In a highly anticipated court decision on November 3, the U.S. District Court for the District of South Carolina ruled that the plain wording of the 340B statute does not require a covered entity to have initiated a healthcare service resulting in a prescription filled with a 340B drug. The judge determined that: “It is not the role of HRSA to legislate and limit the 340B program by restricting the definition of the term ‘patient,’ thereby frustrating the ability of the 340B statute to accomplish its purpose.”

While the decision was limited to Genesis Healthcare, it could have broad implications for the future applicability and enforcement of the patient definition as well as other highly debated matters such as the contract pharmacy program.

Join us November 30th from 1:00-2:00 PM ET for our next subscriber-only webinar where you will hear from three of the nation’s leading drug pricing legal minds on the implications as well as potential limitations of the decision. 

Among the topics to be addressed in this lively discussion:

  • Explanation of the decision and its scope
  • The court’s definition of patient and 340B’s purpose
  • What steps should providers and manufacturers take next, if anything?
  • Chances of a federal appeal 
  • Implications for other highly contested areas such as the contract pharmacy program
  • Potential increased role of Administrative Dispute Resolution process

Speakers include:

  • William von Oehsen, Principal, Powers, Pyles, Sutter and Verville, P.C.
  • Constance Wilkinson, Board of Directors/Member of the Firm, Epstein Becker Green
  • Andrew Ruskin, Partner, K&L Gates
  • Ted Slafsky, Publisher & CEO, 340B Report (Moderator)

Thank you to our webinar sponsors
AIDS Healthcare Foundation, AllianceRx Walgreens Pharmacy,
 Avita Care Solutions, Maxor, Optum,
RxStrategies, and Verity Solutions

This complimentary event is exclusively for 340B Report paid subscribers and sponsors. Subscribers can register for the event after logging in to our website. If your organization is not a paid subscriber (i.e., you do not have a user license), sign up now at a special 25% discount using code WEBINAR25.  As a subscriber, not only do you get our bi-weekly newsletter and full access to our website, but you are also able to attend our timely and informative webinars. The special discount is only available for first-time subscribers.  Free trial subscribers cannot attend the webinar unless they pay for a subscription prior to registration. 

Space is limited. Registration deadline is November 28. Questions?
Email Lee-Anne.Gabrielli@340breport.com.